IMEDEKSA, UAB - financials and debts

Company age: 27 y. 3 mo.

Update

IMEDEKSA - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 4,246,042 4,792,405 5,123,676 7,472,626 8,551,773 5,992,901 5,645,541 6,078,496
Profit before tax 158,258 98,368 550,370 560,212 776,233 687,148 539,184 366,388
Net profit 137,732 90,399 456,576 506,362 670,905 577,459 467,582 309,618
Equity 764,096 854,493 1,124,662 1,158,025 1,828,930 1,759,330 1,626,912 2,293,602
Liabilities 595,604 596,750 1,063,006 958,968 783,539 674,283 842,082 774,214
Non-current assets 793,673 697,844 963,319 1,199,422 1,024,672 904,362 1,481,963 2,146,019
Current assets 632,100 806,584 1,222,189 914,285 1,583,523 1,524,275 1,059,676 984,878
Total assets 1,425,773 1,504,428 2,185,508 2,113,707 2,608,195 2,428,637 2,541,639 3,130,897
Taxes paid
STI taxes - - - - - 276,581 170,726 117,553
Social insurance contributions - - - - - 398,529 393,296 432,376
Financial indicators
Revenue change y/y -1.9% +12.9% +6.9% +45.8% +14.4% -29.9% -5.8% +7.7%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 9.7% 6.0% 20.9% 24.0% 25.7% 23.8% 18.4% 9.9%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 18.0% 10.6% 40.6% 43.7% 36.7% 32.8% 28.7% 13.5%
Profit margin Net profit margin. Shows the overall profitability of the company. 3.2% 1.9% 8.9% 6.8% 7.8% 9.6% 8.3% 5.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 3.7% 2.1% 10.7% 7.5% 9.1% 11.5% 9.6% 6.0%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.8 0.7 0.9 0.8 0.4 0.4 0.5 0.3
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 54,965 57,856 60,755 80,785 90,735 79,114 80,747 83,938

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

IMEDEKSA - Social security debts

From To Debt, €
2025-07-24 2025-08-13 4.68
2025-06-17 2025-06-26 2253.44
2022-12-16 2022-12-27 757.62
2021-10-18 2021-10-24 9881.08

IMEDEKSA - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
IMEDEKSA, UAB (code 141830367) is a Private Limited Liability Company engaged in the manufacture of other builders’ carpentry and joinery, except of wooden prefabricated buildings. In 2025, the company generated revenue of €6.08M and net profit of €309.6K, with a profit margin of 5.1%. Revenue increased by 7.7% year on year in 2025 and by 1.4% over two years, indicating a broadly stable top line after a softer 2024. Profitability has eased over the three-year period, with net profit declining from €577.5K in 2023 to €467.6K in 2024 and €309.6K in 2025. Total assets rose to €3.13M in 2025 from €2.54M in 2024 and €2.43M in 2023, supported by growth in long-term assets to €2.15M. Equity improved to €2.29M, while liabilities were €774.2K. Key ratios point to a solid balance sheet structure, with an equity ratio of 73.3% and debt-to-equity of 0.34. Return on equity was 13.5%, return on assets 9.9%, and asset turnover 1.94x. Revenue per employee was €84.4K in 2025.